Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
ExaCare AI has raised $30 million in a Series A round led by Insight Partners to scale its AI platform for skilled nursing facilities and launch a suite of AI agents aimed at streamlining admissions and care operations.
Harbour BioMed has introduced its first fully human Generative AI HCAb Model, designed to accelerate biologics discovery through AI-driven antibody generation and validation, as announced in a press release.
MCG Health and Allegheny Health Network will discuss how AI can enhance evidence-based care and reduce denials at the 2025 ACMA Leadership & Physician Advisor Conference in Boston.
CareSet has appointed Sepideh Naseri as its first Chief Data and Analytics Officer to oversee data science, engineering, and analytics operations across its Medicare and Medicaid claims data services.
ID.me and Flexpa have announced a partnership to improve patient access to medical records, reduce AI-driven fraud, and support the CMS framework for healthcare interoperability.
Tellihealth has appointed Chuck Washburn as Chief Revenue Officer to lead revenue strategy, go-to-market execution, and customer experience initiatives, reporting to CEO Asif Ahmad.
SK Biopharmaceuticals and Eurofarma have launched Mentis Care, a joint venture based in Toronto, to develop an AI-driven epilepsy management platform combining real-time seizure detection and predictive analytics.
The Chan Zuckerberg Initiative and NVIDIA have expanded their collaboration to accelerate life science research by advancing virtual cell model development through the Virtual Cells Platform.
Sphere has partnered with the National Health Council to promote responsible AI adoption in patient-centered healthcare, focusing on secure data use, improved decision-making, and operational efficiency.
Montefiore Einstein has partnered with Dandelion Health to improve clinical care and accelerate drug development using AI. The collaboration grants Montefiore access to Dandelion's national platform for anonymized patient data, supporting new models for clinical research and patient care.
Generation Lab has raised $11 million in seed funding led by Accel to expand its SystemAge platform, which measures biological aging across 19 organ systems using blood data.
Coral announced it now processes over 500,000 patient workflows monthly and has seen its revenue grow eightfold in seven months, driven by its AI-powered automation platform for healthcare providers.
Beijing Tsingke Biotech presented its AI-powered biomanufacturing platforms at the 2025 Festival of Biologics in Basel, featuring solutions for gene and RNA design, antibody discovery, and scalable biologics production.
Healthcare Outcomes Performance Company (HOPCo) has partnered with Humana to extend its musculoskeletal population health program to Humana members in Arizona, offering integrated digital tools and evidence-based care management.
Fourier Health has secured $8.4 million in seed funding led by Yosemite to advance its clinician-in-the-loop AI platform designed to simplify unstructured patient data and reduce administrative workload in healthcare.
BD has introduced the BD Incada Connected Care Platform and the next-generation BD Pyxis Pro Automated Medication Dispensing Solution, integrating AI and cloud technologies to unify medical device data and improve medication management.
EMMI Technologies has announced its listing on Epic's Showroom, integrating its EmmiTec.Health platform with Epic’s electronic health record system to enhance connected care and real-time patient monitoring.
MGI Tech and Eva Holding Group have formed a strategic partnership to enhance disease monitoring and expand access to genomic sequencing technologies in Brazil, including the first IVD-certified DNBSEQ-T7 sequencer in Latin America.
ManagingLife has launched Solace, an AI companion integrated into its Manage My Pain app, offering evidence-based psychological support for people with chronic pain. A University of Portsmouth study found that a single session with Solace improved pain resilience and reduced anxiety.
Novartis has agreed to acquire Avidity Biosciences for approximately $12 billion in cash, with the deal expected to close in the first half of 2026 following the planned separation of Avidity’s early-stage cardiology programs into a new company called SpinCo.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
